Long-acting medications for the hyperkinetic disorders -: A systematic review and European treatment guideline

被引：270

作者：

Banaschewski, Tobias

Coghill, David

Santosh, Paramala

Zuddas, Alessandro

Asherson, Philip

Buitelaar, Jan

Danckaerts, Marina

Doepfner, Manfred

Faraone, Stephen V.

Rothenberger, Aribert

Sergeant, Joseph

Steinhausen, Hans-Christoph

Sonuga-Barke, Edmund J. S.

Taylor, Eric

机构：

[1] Univ Gottingen, Dept Child & Adolescent Psychiat Psychotherapy, D-37075 Gottingen, Germany

[2] Univ Dundee, Dept Psychiat, Dundee DD1 4HN, Scotland

[3] Great Ormond St Hosp Sick Children, Dept Med Psychol, London WC1N 3JH, England

[4] Maudsley Hosp & Inst Psychiat, Inst Psychiat, London SE5 8AZ, England

[5] Univ Cagliari, Dept Neurosci, I-09124 Cagliari, Italy

[6] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Res Ctr, London WC2R 2LS, England

[7] Radboud Univ Nijmegen Med Ctr, Acad Ctr Child & Adolescent Psychiat, Dept Psychiat, Nijmegen, Netherlands

[8] Univ Hosp Gasthuisberg, Dept Child & Adolescent Psychiat, Louvain, Belgium

[9] Univ Cologne, D-5000 Cologne 41, Germany

[10] SUNY Upstate Med Univ, Med Genet Res Program, Syracuse, NY USA

[11] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY USA

[12] Vrije Univ Amsterdam, Fac Psychol & Educ, Dept Clin Neuropsychol, NL-1081 HV Amsterdam, Netherlands

[13] Univ Zurich, Dept Child & Adolescent Psychiat, CH-8006 Zurich, Switzerland

[14] Univ Southampton, Dept Psychol, Southampton SO9 5NH, Hants, England

[15] Kings Coll London, Inst Psychiat, Dept Chils & Adolescent Psychiat, London WC2R 2LS, England

来源：

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2006年 / 15卷 / 08期

关键词：

guidelines; review; stimulants; atomoxetine; ADHD;

D O I：

10.1007/s00787-006-0549-0

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

A systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers-to-treat for extended-release stimulant preparations and atomoxetine (ATX). A panel of experts from several European countries used the review to make recommendations about the use of these drugs in practice, and conclusions are reported: (1) Long-acting preparations should be available and used; (2) They should not replace short-acting drugs (which will be the initial treatment for many children for reasons of cost and flexibility of dosing). Individual clinical choice is needed. (3) Both ATX and extended-release preparations of stimulants should be available. The choice will depend upon the circumstances, and detailed recommendations are made.

引用

页码：476 / 495

页数：20

共 80 条

[1] Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: An interim analysis [J].